Experienced scientists working directly with your project.

Coulombix is a scientist-led consulting company built around complementary expertise in drug discovery strategy, structural biology, and computational drug design.

40+ YEARS COMBINED EXPERIENCE

Co-Founder

Chris Lee

Drug Discovery Strategy·Pharmacy·Scientific Leadership

Experience

  • GNF / Novartis (1999–2020) · Zentalis (2020–2025)

    Industry & research leadership

Publications & Patents

  • 30 publications · 10+ patents

    Peer-reviewed research and intellectual property

Awards

  • NIBR Team Award

    LDK378 / Zykadia (ALK inhibitor team)

  • Zentalis Executive Leadership Team Excellence Award

    Development Candidate Nomination

  • Structural biology and SBDD in multidisciplinary discovery teams.

    Deep experience delivering and interpreting ligand–target co-structures to advance discovery programs.

  • Integrates medicinal chemistry and structural biology.

    Combines structural insights, chemistry, and SAR to guide design decisions.

  • Program perspective and scientific leadership.

    Brings strategic and operational experience across discovery-stage research and decision making.

Contact Coulombix